Astria Therapeutics logo

Astria Therapeutics Share Price Today

(NASDAQ: ATXS)

Astria Therapeutics share price is $6.23 & ₹541.82 as on 6 Mar 2025, 2.30 'hrs' IST

$6.23

0.02

(0.32%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Astria Therapeutics share price in Dollar and Rupees. Guide to invest in Astria Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Astria Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Astria Therapeutics share price movements

  • Today's Low: $6.11
    Today's High: $6.29

    Day's Volatility :2.86%

  • 52 Weeks Low: $6.07
    52 Weeks High: $16.90

    52 Weeks Volatility :64.08%

Astria Therapeutics (ATXS) Returns

PeriodAstria Therapeutics IncIndex (Russel 2000)
3 Months
-36.31%
0.0%
6 Months
-45.91%
0.0%
1 Year
-57.76%
0.0%
3 Years
-1.58%
-11.6%

Astria Therapeutics (ATXS) Key Statistics

in dollars & INR

Previous Close
$6.21
Open
$6.19
Today's High
$6.29
Today's Low
$6.11
Market Capitalization
$344.2M
Today's Volume
$79.5K
52 Week High
$16.9
52 Week Low
$6.07
Revenue TTM
$0.0
EBITDA
$-32.4M
Earnings Per Share (EPS)
$-2.18
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-38.03%

How to invest in Astria Therapeutics Stock (ATXS) from India?

It is very easy for Indian residents to invest directly in Astria Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Astria Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Astria Therapeutics or ATXS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Astria Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Astria Therapeutics shares which would translate to 0.140 fractional shares of Astria Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Astria Therapeutics, in just a few clicks!

Returns in Astria Therapeutics (ATXS) for Indian investors in Rupees

The Astria Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Astria Therapeutics investment value today

Current value as on today

₹47,344

Returns

₹52,656

(-52.66%)

Returns from Astria Therapeutics Stock

₹57,619 (-57.62%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Astria Therapeutics (ATXS)

233%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Astria Therapeutics Stock from India on INDmoney has increased by 233% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Astria Therapeutics

  • FMR Inc

    13.86%

  • Perceptive Advisors LLC

    11.49%

  • RA Capital Management, LLC

    9.05%

  • Vestal Point Capital LP

    7.41%

  • BlackRock Inc

    6.91%

  • Fairmount Funds Management LLC

    6.30%

Analyst Recommendation on Astria Therapeutics

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Astria Therapeutics(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
12
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Astria Therapeutics Stock (ATXS)

What analysts predicted

Upside of 325.36%

Target:

$26.50

Current:

$6.23

Insights on Astria Therapeutics Stock (Ticker Symbol: ATXS)

  • Price Movement

    In the last 3 months, ATXS stock has moved down by -36.3%
  • ATXS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 117.5%
  • ATXS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 46.2%

Astria Therapeutics Technicals Summary

Sell

Neutral

Buy

Astria Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Astria Therapeutics (ATXS) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Astria Therapeutics Inc logo
-16.42%
-45.91%
-57.76%
-1.58%
-26.07%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Astria Therapeutics Inc logo
NA
NA
NA
-1.95
-0.38
-0.23
NA
4.37
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Astria Therapeutics Inc logo
Buy
$344.2M
-26.07%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Astria Therapeutics

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in Phase 1b/2 clinical trials for the treatment of hereditary angioedema. The company is also developing STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, an immune disorder associated with loss of skin barrier function and itching. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is headquartered in Boston, Massachusetts.
Organization
Astria Therapeutics
Employees
59
CEO
Ms. Jill C. Milne Ph.D.
Industry
Miscellaneous

Management People of Astria Therapeutics

NameTitle
Ms. Jill C. Milne Ph.D.
Co-Founder, CEO, President & Director
Mr. Noah C. Clauser CPA
CFO & Treasurer
Dr. Christopher J. Morabito M.D.
Chief Medical Officer
Mr. Benjamin S. Harshbarger J.D.
Chief Legal Officer
Ms. Keri McGrail
Chief Human Resources Officer
Ms. Andrea L. Matthews
Chief Business Officer
Mr. Andrew A. Komjathy
Chief Commercial Officer
Mr. John Ruesch
Senior Vice President of Pharmaceutical Sciences & Technical Operations
Ms. Rafif Dagher
Senior VP and Head of Discovery, Nonclinical Development & Translational Research

Important FAQs about investing in ATXS Stock from India :

What is Astria Therapeutics share price today?

Astria Therapeutics share price today stands at $6.23, Open: $6.19 ; Previous Close: $6.21 ; High: $6.29 ; Low: $6.11 ; 52 Week High: $16.90 ; 52 Week Low: $6.07.

The stock opens at $6.19, after a previous close of $6.21. The stock reached a daily high of $6.29 and a low of $6.11, with a 52-week high of $16.90 and a 52-week low of $6.07.

Can Indians buy Astria Therapeutics shares?

Yes, Indians can invest in the Astria Therapeutics (ATXS) from India.

With INDmoney, you can buy Astria Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Astria Therapeutics at zero transaction cost.

How can I buy Astria Therapeutics shares from India?

It is very easy to buy Astria Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Astria Therapeutics (ATXS) be purchased?

Yes, you can buy fractional shares of Astria Therapeutics with INDmoney app.

What are the documents required to start investing in Astria Therapeutics stocks?

To start investing in Astria Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Astria Therapeutics Stock (ATXS)?

Today’s highest price of Astria Therapeutics (ATXS) is $6.29.

Today’s lowest price of Astria Therapeutics (ATXS) is $6.11.

What is today's market capitalisation of Astria Therapeutics?

Today's market capitalisation of Astria Therapeutics ATXS is 344.2M

What is the 52 Week High and Low Range of Astria Therapeutics Stock (ATXS)?

  • 52 Week High

    $16.90

  • 52 Week Low

    $6.07

What are the historical returns of Astria Therapeutics (ATXS)?

  • 1 Month Returns

    -16.42%

  • 3 Months Returns

    -45.91%

  • 1 Year Returns

    -57.76%

  • 5 Years Returns

    -26.07%

Who is the Chief Executive Officer (CEO) of Astria Therapeutics ?

Ms. Jill C. Milne Ph.D. is the current Chief Executive Officer (CEO) of Astria Therapeutics.